9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Pfizer
Massive Bio, Inc.
Ryvu Therapeutics SA
IGM Biosciences, Inc.
Adaptimmune
Vector Vitale LLC
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Amgen
Celgene
Curon Biopharmaceutical (Australia) Co Pty Ltd
Adaptimmune
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Synta Pharmaceuticals Corp.
Novacea